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Abstract
Due to the overprescription and misuse of antibiotics, an environment has been
created which has allowed a number of resistant organisms to flourish. These organisms
mediate their resistance through a variety of means. Those organisms which have
become resistant to the aminoglycoside class of antibiotics carry out their resistance
through one of three classes of modifying enzymes. These classes are
phosphotransferases, nucleotidyl transferases, and acetyl transferases. The
aminoglycoside phosphotransferases (APH) detoxify an amino glycoside by adding a
phosphate to the antibiotic from an ATP molecule. APH(3')-llIa is one of the most well
studied phosphotransferases due in fact to its crystal structure having been solved. In this
study, we make use of some of the exchange-inert metal-ATP analogues. Using these,
we have shown that a second metal ion in the crystal structure of APH(3')-Illa does not
playa role in catalysis or ATP binding.

Introduction

The resistance to antibiotics is a growing problem in this country and throughout
the world. Through such means as conjugation and transfection, bacteria are able to
transfer R-plasmids that carry genes for various resistance enzymes. This has allowed for
the rapid spread of resistance enzymes through a number of organisms. It is critical that
scientists understand how these enzymes work in order to combat their action.
The aminoglycoside antibiotics are carbohydrate-based molecules that kill
bacteria by terminating protein synthesis. These antibiotics mediate this by binding to the
30S subunit of the ribosome and thereby preventing the initiation of protein synthesis
(Tanaka, 1982). Unfortunately, soon after these new antibiotics were discovered,
resistant organisms soon appeared. It has now been characterized that there are three
classes of enzymes that detoxify amino glycoside antibiotics by modifying them. These
classes are the nuc1eotidyl transferases (ANT), acetyl transferases (AAC), and the
phosphotransferases (APH) (Shaw et aI., 1993).
The enzyme of focus in this study is APH(3 ')-IlIa. As indicated by the
nomenclature, this enzyme catalyzes the transfer of the y-phosphate of an ATP molecule
to the 3' hydroxyl of an amino glycoside. This enzyme is well-studied due to the fact that
Hon and colleagues (1997) have solved the crystal structure for this enzyme. This has
given researchers a type of road map to direct future research. In the case ofthis study,
crystallography determined that there are two magnesium ions in the active site of
APH(3 ')-IlIa. One of the magnesium ions is coordinated to the

p and y phosphates of

ATP. The role of the second metal ion was unknown. This study uses the aid of
exchange-inert Metal-ATP complexes to elucidate the role of this second magnesium ion.

The magnesium, the ion nonnally coordinated to an ATP molecule at nonnal
physiological conditions, exchanges at a very high rate and is spectroscopically very
uninteresting. In order to study the role metal ions play in certain enzymes, magnesium
can be replaced with a metal ion that does not exchange its ligands at a high rate
(Dunaway-Mariano and Cleland, 1980). These exchange-inert Metal-ATP complexes
have been used to study a number of enzymes in this and other labs (Serpersu et aI.,
1992; Pappu et aI., 1994; Dunaway-Mariano and Cleland, 1980). By using these
complexes in this study, one can specify one of the two metal ions present. Then, the
second ion can be added, and the effect on inactivation or activity can be ascertained.
This study makes use of both CrATP and RhATP. CrATP was used in this study
to look at the role of the second magnesium in MeATP binding. Previous unpublished
research in this lab has shown that CrATP inactivates APR(3')-IIIa in a pseudo-first
order reaction. This inactivation can be modeled to the nonnal binding of ATP to the
enzyme. Any effects added magnesium has on inactivation can be connected to its
effects on ATP binding. The paramagnetic nature of chromium precludes its use in
NMR. This is why RhATP, a diamagnetic Metal-ATP complex, was used. RhATP was
used as a substrate in an NMR tube to follow the reaction of APR by 31 p NMR. This
sensitive technique would elucidate any effect added magnesium has on catalysis.
Materials and Methods

1. Materials
CrATP was prepared by the method of Dunaway-Mariano and Cleland (1980).
The concentration ofCrATP was detennined spectrophotometric ally by measuring the
absorbances at 427 nm (E=30 M- I em-I), 606 nm (E=25 M- I em-I), and 258 nm (E=15,800

M- I cm- I ). RhATP was prepared by first synthesizing rhodium (III) perchlorate
hexahydrate by the method of Ayres and Forrester (1957) and then following the
procedure of Lu et al. (1988). RhATP was prepared as a 50150 mixture of ~,y-bidentate
and a,~,y-tridentate RhATP by heating the reaction mixture for ten minutes at 80°. The
presence ofa 50150 mixture was confirmed by 31 p NMR. Concentration ofRhATP was
I

determined spectrophotometric ally at 258 nm (E=15,800 M- cm-

I

).

APH(3')-Illa was

overexpressed in Escherichia coli (BL-21 strain) and purified as described by McKay et
al. (1994). All chemicals used were of the highest grade available.

2. APH(3 ')-IIIa Activity Assay
Activity of APH(3 ')-IlIa was determined by using a coupled enzyme reaction. The
ADP formed in the APH reaction reacts with phosphoenolpyruvate (PEP) to form ATP
and pyruvate via pyruvate kinase (PK). The pyruvate is then used by lactate
dehydrogenase (LDH) to oxidize NADH. One can follow the reaction by monitoring the
rate of oxidation at 340 nm. This reaction is carried out in a mixture of 100 mM KCl,
20.4 mM MgClz, 50 mM MES (pH 6.5), .34 mM NADH, 2.0 mM PEP
(cyc1ohexylammonium salt), 0.5 mM Kanamycin A, 10.2 mM ATP, 90 units ofPK, and
55 units ofLDH. APH(3')-IIIa was added to a concentration of 112 J.lg/mL, and NADH
oxidation was measured at 340 nm with a Beckman DU-70 spectrophotometer at 37°C.

3. CrATP Inactivation Studies
APH(3 ')-IlIa has previously been shown to be inactivated by incubation with
CrATP (Cox, Ph.D. dissertation). The inactivation was carried out at 37°C in a 200 J.lL
mixture of the following: 100 mM KCl, 3.7 mg mL- I APH(3')-I1Ia, 50 mM MES (PH
6.5), and 0.4 mM CrATP. In some experiments, either EDTA or MgClz was added to

obtain concentrations of 0.5 mM and 2 mM, respectively. At certain time intervals
during the incubation, 25-flL aliquots were removed from the incubation mixture and
assayed as described above to determine loss of activity.

3. RhATP NMR Studies
A 500-flL solution (10% D 2 0) of25 mM MES (pH 6.5), 3.4 mM RhATP, 0.84
mM Kanamycin A, and 0.89 mM APH(3')-IIIa was monitored by 31 p NMR to study the
catalytic cycle of APH. MgCh in one experiment was added to 2 mM. Spectra were
taken with a Bruker AMX-400 wide-bore spectrometer with a 5-mm quad-nuclear probe.
Spectra were processed and analyzed using Felix 95.0 software from Biosym®.

Results
Inactivation of APH(3')-IIIa by CrATP has previously been shown to be a
pseudo-first order reaction (Cox, Ph.D. dissertation). Inactivation experiments were
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carried out as described in both the absence and addition of added MgClz to detennine the
role of the second Mg++ ion in MeATP binding. EDTA was added in one experiment to
ensure there were no contaminating metal ions present in the enzyme. As can be seen
from Figure 1, there was no significant effect on CrATP inactivation rates by the addition
of MgClz.
RhATP

31 p

spectra were collected in both the absence and addition of MgClz to

study the role of the second Mg++ ion in catalysis. The first set of spectra (Figure 2)

Figure 2 - Spectra with No Added Mg++

Figure 3 - Spectra with Added Mg++

shows the progression of the APH reaction without added MgCb. The top spectrum is
the beginning of the reaction. Each spectrum is a collection of 4000 scans taken over a
two-hour period. In Figure 3, one can see the set of spectra in which the reaction was run
in the presence of added MgCb. Again, the top is the beginning ofthe reaction and each
spectrum is composed of 4000 scans.

The chemical shifts of the a,p,y-bidentate phosphorus atoms are at points 6900,
5600, and 3700, respectively. Likewise, the chemical shifts of the a,p,y-bidentate
phosphorus atoms are at points 4900, 5700, and 3650, respectively. As phosphorylated
aminoglycoside is formed, its peak grows at 4900 underneath the a-tridentate phosphorus
resonance. Product formation is accompanied by the attenuation of the y-bidentate
phosphorus resonance at 5600. This is consistent with the known reaction. At point
3800, one can see the formation of a new peak. As Cr3+ coordinates to the enzyme over
time, it causes a change in chemical environment, and thereby chemical shift, for the yphosphorus atoms.
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Figure 4
The integration of the product peak was divided by the integration of the pphosphorus peak in order to standardize the integrations across the different spectra.
These ratios were then plotted against time to determine the rate of product formation in
both absence and addition ofMgClz (Figure 4). As can be seen, the presence of MgClz
does not significantly alter the rate of product formation.

Discussion

These studies with exchange-inert metal-ATP complexes have elucidated the role
of the second metal ion found in APH(3')-IIIa. The result that added magnesium had no
effect on CrATP inactivation suggests that the second metal ion does not playa role in
MeATP binding. Likewise, the rate of product formation as determined by RhATP and
31p

NMR showed no visible change with the addition of magnesium. This shows that the

second magnesium ion does not playa role in catalytic activity. Possible roles for this
second metal ion include the stabilization of the active site or the enzyme itself. One
might argue that the second magnesium is bound to APH(3 ')-llIa from expression and
purification. This would definitely explain the similarity in the results between the
absence and addition ofMg++. However, this is unlikely due to the fact the magnesium is
exposed to the surface ofthe enzyme and, as previously mentioned, coordinates and
dissociates at a very high rate.
There are a few implications for the information gathered in this study. The
ultimate goal in understanding the mechanisms ofthe aminoglycoside modifying
enzymes is to use the information in rational drug design. Due to its lack of activity in
binding or catalysis, it is now known that the second magnesium ion will not be a good
candidate for interactions with any designed inhibitor. Other targets for drug design in
the enzyme will need to be found. Fortuitously, ongoing research in this lab has shown
the presence of an essential tyrosine. Time will eventually elucidate this prime target for
drug design.
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